Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Hypertension

Do calcium-channel blockers increase breast cancer risk?

Nature Reviews Cardiology volume 10, pages 621–622 (2013)Cite this article

Subjects

A case–control study of five classes of antihypertensive medication used among 2,851 women shows that taking calcium-channel blockers for ≥10 years is associated with increased risk of invasive ductal and lobular breast carcinoma. These results are intriguing, but warrant additional investigation given the study limitations and inconsistent findings in the literature.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kearney, P. M. et al. Global burden of hypertension: analysis of worldwide data. Lancet 365, 217–223 (2005).

    Google Scholar 

  2. Li, C. I. et al. Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years. JAMA Intern. Med. http://dx.doi.org/10.1001/jamainternmed.2013.9071.

  3. Fitzpatrick, A. L., Daling, J. R., Furberg, C. D., Kronmal, R. A. & Weissfeld, J. L. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer 80, 1438–1447 (1997).

    Article  CAS  Google Scholar 

  4. Pahor, M. et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet 348, 493–497 (1996).

    Article  CAS  Google Scholar 

  5. Oparil, S. et al. Mortality and morbidity during and after antihypertensive and lipid-lowering treatment to prevent heart attack trial results by sex. Hypertension 61, 977–986 (2013).

    Article  CAS  Google Scholar 

  6. Michels, K. B. et al. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U. S. women: the Nurses' Health Study. Cancer 83, 2003–2007 (1998).

    Article  CAS  Google Scholar 

  7. Fryzek, J. P. et al. A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast Cancer Res. Treat. 97, 231–236 (2006).

    Article  Google Scholar 

  8. Bangalore, S. et al. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol. 12, 65–82 (2011).

    Article  CAS  Google Scholar 

  9. Mason, R. P. Calcium channel blockers, apoptosis and cancer: is there a biologic relationship? J. Am. Coll. Cardiol. 34, 1857–1866 (1999).

    Article  CAS  Google Scholar 

  10. Holmes, M. D., Hankinson, S. E., Feskanich, D. & Chen, W. Y. Beta blockers and angiotensin-converting enzyme inhibitors' purported benefit on breast cancer survival may be explained by aspirin use. Breast Cancer Res. Treat. 139, 507–513 (2013).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of Stanford University School of Medicine or Harvard Medical School.

Author information

Authors and Affiliations

  1. Department of Medicine, Stanford University School of Medicine, 291 Campus Drive, Stanford, 94305, CA, USA

    Ange Wang

  2. Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, 900 Commonwealth Avenue, Boston, 02215, MA, USA

    JoAnn E. Manson

Authors
  1. Ange Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. JoAnn E. Manson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to JoAnn E. Manson.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, A., Manson, J. Do calcium-channel blockers increase breast cancer risk?. Nat Rev Cardiol 10, 621–622 (2013). https://doi.org/10.1038/nrcardio.2013.155

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2013.155

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing